Throughout the last three months, 5 analysts have evaluated Medpace Hldgs (NASDAQ:MEDP), offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 1 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
Analysts have recently evaluated Medpace Hldgs and provided 12-month price targets. The average target is $437.0, accompanied by a high estimate of $480.00 and a low estimate of $395.00. This current average reflects an increase of 26.12% from the previous average price target of $346.50.
Exploring Analyst Ratings: An In-Depth Overview
A comprehensive examination of how financial experts perceive Medpace...
Login or create a forever free account to read this news
Sign up/Log in